[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Gesundheit

FDA-Zulassung AbbVie Tavapadon – redaktionelle Illustration
FDA: Tavapadon von AbbVie für Parkinson zugelassen
Die US-Arzneimittelbehörde FDA hat am Freitag Tavapadon von AbbVie (ABBV.N) als einmal täglich einzunehmende Parkinson-Tablette zugelassen – ein Meilenstein, der Analysten zufolge über $5 Milliarden Jahresumsatz einbringen könnte. Für Anleger ist die Zulassung bedeutsam,...
biotech consolidation illustration
Pfizer's $2B Vaccine Standoff Eyes Air-Traffic Fees
Pfizer (PFE) is pressing a roughly $2 billion arbitration claim against Poland and Romania over cancelled...
Smithfield Faces Pork Segment Loss Amid Margin Collapse
Smithfield Foods (SFD.O) shares fell nearly 2% in extended trading on Tuesday after the pork giant said its fresh pork segment will swing to an adjusted...
Ionis Secures FDA Nod for First Alexander Therapy
Nestlé Invests Heavily in Brazil Infant Formula Sector
Novartis Faces CAR-T Challenges in Autoimmune Trials
JBS Billionaire Spurs Shift in U.S. Beef Tariffs
J&J's Imaavy: A Breakthrough in Rare Blood Disorder
biotech consolidation illustration
Regenxbio Slump: Spine Nodules Halt Therapy Trial
1 month ago
Regenxbio (RGNX) shares plunged roughly 22% on Monday after regulators imposed a clinical hold on RGX-121, the company’s investigational gene therapy for Hunter syndrome,...
Guardant Health patent verdict illustration
Guardant Health's $245M Patent Setback & Its Implications
1 month ago
A Delaware federal court has handed Guardant Health (GH) a $245.2 million final judgment for willful DNA-sequencing patent infringement, imposing ongoing royalties on products...
gilead ouro deal illustration
Regeneron's Pasatru Enters Ultra-Rare Bone Market
1 month ago
Regeneron Pharmaceuticals (REGN.O) surged 4% Wednesday after the FDA approved Pasatru for a bone-hardening disorder, adding a second approved rival to Ipsen’s Sohonos in...
Pilgrim's Pride buyout impact illustration
JBS Eyes Full Control: Pilgrim's Pride Buyout Impact
1 month ago
JBS (JBSS3.SA), the world’s largest meatpacker, proposed Monday to acquire the roughly 18% of Pilgrim’s Pride (PPC) it does not already own, a move that would consolidate...
biotech consolidation illustration
Hilleman Bios Boosts Congo Vaccine Drive Amid Crisis
2 months ago
Hilleman Laboratories, the Singapore-based Merck (MRK) and Wellcome joint venture, is manufacturing an experimental Bundibugyo-strain Ebola vaccine for clinical trials as Congo’s...
WEITERE NACHRICHTEN
TAVR sales growth Q2 illustration
Edwards Lifesciences' TAVR Sales Propel Q2 Success
2 months ago
gilead ouro deal illustration
Roche's CER Growth Outshines Swiss Franc Impact
2 months ago
Platinum Equity JV illustration
Nestlé and Platinum Equity Forge Waters JV Deal
2 months ago
KATEGORIEN